Literature DB >> 25047186

Research and development of photodynamic therapy photosensitizers in China.

De-Yu Xu1.   

Abstract

Photodynamic therapy (PDT) started in the People's Republic of China in the early 1980s after hematoporphyrin derivative (HpD) was used in China as PDT photosensitizer in clinical PDT for the treatment of various cancers. Since then, numerous domestic photosensitizers have been synthesized and evaluated. In general, the research and development of PDT photosensitizers in China can be divided into two stages. Firstly, attention was focused on the development of mixed porphyrin preparations similar to HpD and Photofrin II, and the second stage was searching for new photosensitizers with definite structures. In the past 2 decades three mixed porphyrin preparations and a series of new photosensitizers with different structures were developed and entered into formal clinical trials in China. This manuscript will introduce past research and development activities in China and present published preclinical and clinical data of some promising photosensitizers.

Entities:  

Year:  2006        PMID: 25047186     DOI: 10.1016/j.pdpdt.2006.09.003

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  7 in total

1.  Experimental study on the photodynamic treatment of choroidal neovasculization with nanophthalocyanine photosensitizer.

Authors:  Song-Yi Wu; Guo-Xing Xu; Yi-Ru Peng; Xiao-Fang Zhou; Jian Guo
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

Review 2.  A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.

Authors:  Qizhi Zhang; Jun He; Wenmei Yu; Yanchun Li; Zhenhua Liu; Binning Zhou; Yunmei Liu
Journal:  RSC Med Chem       Date:  2020-02-25

3.  HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma.

Authors:  Shan-Yi Zhang; Jun-Liang Li; Xin-Ke Xu; Mei-Guang Zheng; Cheng-Cai Wen; Fang-Cheng Li
Journal:  J Neurooncol       Date:  2011-04-26       Impact factor: 4.130

4.  Dark and Photoinduced Cytotoxic Activity of the New Chlorophyll-a Derivatives with Oligoethylene Glycol Substituents on the Periphery of Their Macrocycles.

Authors:  Yana I Pylina; Dmitry M Shadrin; Oksana G Shevchenko; Olga M Startseva; Igor O Velegzhaninov; Dmitry V Belykh; Ilya O Velegzhaninov
Journal:  Int J Mol Sci       Date:  2017-01-05       Impact factor: 5.923

Review 5.  Crossed and linked histories of tetrapyrrolic macrocycles and their use for engineering pores within sol-gel matrices.

Authors:  Miguel A García-Sánchez; Fernando Rojas-González; E Carmina Menchaca-Campos; Salvador R Tello-Solís; R Iris Y Quiroz-Segoviano; Luis A Diaz-Alejo; Eduardo Salas-Bañales; Antonio Campero
Journal:  Molecules       Date:  2013-01-04       Impact factor: 4.411

6.  Quantification of a Novel Photosensitizer of Chlorin e6-C15-Monomethyl Ester in Beagle Dog Plasma Using HPLC: Application to Pharmacokinetic Studies.

Authors:  Xiuxiu Li; Jun Wen; Jingjing Jiang; Xin Zhao; Tingting Zhou; Guorong Fan
Journal:  Molecules       Date:  2017-04-26       Impact factor: 4.411

7.  A medical manipulator system with lasers in photodynamic therapy of port wine stains.

Authors:  Xingtao Wang; Chunlai Tian; Xingguang Duan; Ying Gu; Naiyan Huang
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.